Dr. Nicola Mason

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

August 02, 2021

Medical Brief: Histiocytic Sarcoma

July 26, 2021

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

July 12, 2021

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

June 30, 2021

Topics

One post • B.Vet.Med, PhD, DACVIM (Internal Medicine)

Featuring

Dr. Gerry Post, The Internet

Dr. Nicola Mason, B.Vet.Med, PhD, DACVIM (Internal Medicine)

Personalized Medicine: Because Not All Tumors Are Created Equally

Dr. Mason shares insight from the groundbreaking work her team is doing with hemangiosarcoma genetics and discussses the findings from her research on immunology and its influence on the future of veterinary medicine.

Dr. Gerry Post Dr. Nicola Mason

Aug 14 • 7 min read

Webinars

Discover more content...

Enter some keywords in the search box above, we will do our best to offer you relevant results.

Results

We're sorry!

We couldn't find any results for your search. Please try again with another keywords.

Success! Your account is fully activated, you now have access to all content.

Recent articles

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Medical Brief: Histiocytic Sarcoma

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Topics

Dr. Nicola Mason

Personalized Medicine: Because Not All Tumors Are Created Equally

Discover more content...

Results

We're sorry!

Recent articles

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Medical Brief: Histiocytic Sarcoma

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Topics